Here you can find a collection of publications by ESCMID.

• Joint ESCMID, FEMS, IDSA, ISID and SSI position paper on the fair handling of career breaks among physicians and scientists when assessing eligibility for early-career awards.Huttner A, Bricheux A, Buurmeijer-van DijK CJM et al. Clin Microbiol Infect 2021; in press. doi: 10.1016/j.cmi.2021.01.029.

• European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Guidelines for 1 the Treatment of Infections Caused by Multidrug-Resistant Gram-Negative Bacilli (endorsed 2 by ESICM –European Society of Intensive Care Medicine)
  Paul M, Carrara E, Retamar P et al. Clin Microb Infect 2021; Article in press. doi: 10.1016/j.cmi.2021.11.025
• ESCMID COVID-19 Living guidelines: drug treatment and clinical management
  Bartoletti M, Azap O, Barac A et al. Clin Microb Infect 2021; Article in press. doi: 10.1016/j.cmi.2021.11.007
• Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease (with ESCMID endorsement). 
  Lantos P M, Rumbaugh J, Bockenstedt L K et al. Clin Infect Dis 2021; 72: e1–e48. doi: 10.1093/cid/ciaa1215
• Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
  Evans L, Rhodes  A, Alhazzani W et al. Intensive Care Med 2021; 2: 1-67. doi: 10.1007/s00134-021-06506-y
• European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults
  van Prehn J, Reigadas E, Vogelzang EH et al. Clin Microb Infect 2021; Article in press. doi: 10.1016/j.cmi.2021.09.038

ESGBOR

• Serodiagnosis of Lyme borreliosis-is IgM in serum more harmful than helpful?Hillerdal H, Henningsson A J Eur J Clin Microbiol Infect Dis 2021. doi: 10.1007/s10096-020-04093-2.

ESGCD

• The other 'C': Hospital-acquired Clostridioides difficile infection during the coronavirus disease 2019 (COVID-19) pandemic. Hazel K, Skally M, Glynn E et al. Infect Control Hosp Epidemiol 2021; 13: 1-2. doi: 10.1017/ice.2021.3.

ESGFOR

• Microbiology in minimally invasive autopsy: best techniques to detect infection. ESGFOR (ESCMID study group of forensic and post-mortem microbiology) guidelines.
  Saegeman S, Cohen M C, Burton J L et al. Forensic Sci Med Pathol 2021; 19: 1-14. doi: 10.1007/s12024-020-00337-x.
  
  
  

ESGIAI

• The EBJIS definition of periprosthetic joint infection: a practical guide for clinicians.
  McNally M, Sousa R, Wouthuyzen-Bakker M et al. Bone Jt J 2021; 103-B: 18 – 25. doi: 10.1302/0301-620X.103B1.BJJ-2020-1381.R1
  
  

ESGIE

• Prevention of the spread of multidrug-resistant organisms in nursing homes.
  Tinelli M, Tiseo G, Falcone M et al. Aging Clin Exp Res 2021;33: 679-687. doi: 10.1007/s40520-020-01746-2.
  
  
  

ESGLI

• Legionella antibiotic susceptibility testing: is it time for international standardisation and evidence-based guidance? Portal E, Descours G, Ginevra C et al. Antimicrob Chemother 2021; dkab027. doi: 10.1093/jac/dkab027.

ESGNI

• Operating theatre attire (scrub suits) worn outside the operating theatre. Infection risk or not.
  Humphreys H, Bak A, Mugglestone M A et al. J Hosp Infect 2021; 108: 209-211. doi: 10.1016/j.jhin.2020.12.002.
• Ultraviolet disinfection robots to improve hospital cleaning. Real promise or just a gimmick?
  Diab‑El Schahawi M, Zingg W, Vos M et al. Antimicrob Resist Infect Control 2021; 10:33. doi: 10.1186/s13756‑020‑00878.
  
  

ESGMYC

• Co-administration of treatment for rifampicin-resistant TB and chronic HCV infection: A TBnet and ESGMYC studyTunesi S, Le Dû D, Gualano G et al. Journal of Infection 2022; https://doi.org/10.1016/j.jinf.2022.03.004

To top